ESG

With one trial halted and another beginning, the company focuses its cash and hopes on BBI-940, a novel drug targeting a fundamental driver of cancer.

A new non-thermal ablation technology shows long-term success in shrinking thyroid nodules with high patient satisfaction, potentially disrupting surgical norms.

A new AI-designed drug shows promise in selectively burning fat while preserving muscle, with a potential twice-yearly dosing schedule for obesity.

A Vietnamese company has launched a new infant formula with IgHM, an ingredient designed to replicate the immune antibodies found in human breast milk.

Canada Nickel secures a critical power deal with Hydro One, a major step for its net-zero nickel mine, built on a foundation of Indigenous partnership.

UK's Abselion opens a US base in Cambridge, MA, aiming to disrupt biologics R&D with its rapid Amperia protein quantification system.

IDEAYA Biosciences begins a key trial for its targeted therapy IDE892, aiming to conquer hard-to-treat tumors and pivoting to focus on its proprietary assets.

Hong Kong's OP Investment Management reports record 2025 growth, riding historic rallies in China and Korea to solidify its role as a key platform.

Moving to FAST platforms, Mind-Sync TV pioneers 'Functional TV,' a new category of 4K content designed to enhance focus, not just entertain.

With its runway extended by insiders, the biotech firm bets on its promising glioblastoma drug and an unconventional strategy of crypto and acquisitions.

With new federal funding and key milestones met, E3 Lithium's DLE technology is set to unlock vast lithium resources from Alberta's oil brines.

Beijing is pouring trillions into AI, 6G, and biomanufacturing to dominate the next tech era, offering Europe partnership amidst rising competition.

Early access programs for a rare blindness therapy in France, Israel, and the US offer hope to patients and provide a crucial financial lifeline for the company.

A new trial in China tests a dual-action antibody for esophageal cancer, a top killer. The therapy aims to unleash a two-pronged immune attack on tumors.

An in-depth look at the Nooro foot massager reveals a gap between its marketing claims, FDA clearance, and a pattern of customer service complaints.

Eightpoint's updated NewsNow Home app promises to deliver calm, hyperlocal news. But user experience issues reveal a deep disconnect from its lofty vision.

As AI reshapes medicine, one veterinary firm's 'No AI' policy is earning major awards and the loyalty of the vets it serves. Here's why.

New disposable encounter-sensing wristbands unveiled at HIMSS 2026 aim to automate clinical documentation, giving valuable time back to patient care.

On the eve of International Women's Day, top officials warn that persistent pay gaps, housing insecurity, and new AI threats challenge Canada's progress.

Dr. Pietro Garbelli's award-winning book offers a crucial roadmap for responsibly integrating AI, balancing high-tech innovation with patient trust.